借力推动前列腺癌 CAR-T 细胞治疗进展
Piggybacking toward Progress for CAR T-Cell Therapy in Prostate Cancer.
P-PSMA-101 是一款首创的、富集干细胞记忆 T 细胞的、靶向前列腺特异性膜抗原(PSMA)的嵌合抗原受体(CAR)T 疗法。
英文原题:Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes.
这些结果表明,在肿瘤区域内发现的调节性 T 细胞和记忆 T 细胞比例是前列腺癌晚期全身进展的强有力且独立的预测因子。
引言:TIL(肿瘤浸润淋巴细胞)的定位、密度,尤其是表型,可为宿主免疫系统与肿瘤之间的初始相互作用提供重要信息。本研究旨在评估前列腺癌(PCa)中 T 细胞(CD3+)、调节性 T 细胞(Treg;FoxP3+)、记忆 T 细胞(Tmem;CD45RO+)浸润淋巴细胞及 TIL 相关基因的预后意义。方法:在 98 例具有长期临床随访的 PCa 样本中,采用免疫组织化学(IHC)评估肿瘤区域、肿瘤边缘及邻近正常样上皮中的 CD3+、FoxP3+ 和 CD45RO+ 细胞浸润。在另一组 50 例具有长期随访的肿瘤中,使用 Taqman 低密度阵列(TLDA)技术分析 31 个 TIL 相关基因组成的面板。采用 Kaplan-Meier 和 Cox 比例风险回归分析,确定这些标志物与生化复发(BCR)、需要确定性雄激素剥夺治疗(ADT)或致死性 PCa 的关联。结果:肿瘤、肿瘤边缘和邻近正常样上皮中 TIL 亚型密度不同,但肿瘤区域中的密度和表型对临床结局的预测力最强。多变量分析显示,Treg 密度高(FoxP3+/CD3+ 细胞比值高)预测确定性 ADT 需求风险升高(HR=7.69,p=0.001)和致死性 PCa 风险升高(HR=4.37,p=0.04)。相反,Tmem 密度高(CD45RO+/CD3+ 细胞比值高)预测致死性 PCa 风险降低(HR=0.06,p=0.04)。TLDA 分析显示,FoxP3 高表达与致死性 PCa 风险升高相关(HR=5.26,p=0.02)。CTLA-4、PD-1、TIM-3 和 LAG-3 表达与 FoxP3 表达相关。在这些标志物中,只有 TIM-3 高表达在单变量 Cox 回归分析中与确定性 ADT 风险显著升高相关(HR=3.11,p=0.01)。结论:结果显示,肿瘤区域中的 Treg 和 Tmem 比例是 PCa 晚期全身进展的强效独立预测因素。结果还提示,抑制 TIM-3 可能有助于抵消 Treg 的免疫抑制作用,从而增强针对 PCa 的抗肿瘤免疫反应。
INTRODUCTION: The localization, density but mostly the phenotype of tumor infiltrating lymphocytes (TIL) provide important information on the initial interaction between the host immune system and the tumor. Our objective was to assess the prognostic significance of T (CD3 + ), T regulatory (T reg ) (FoxP3 + ) and T memory (T mem ) (CD45RO + ) infiltrating lymphocytes and of genes associated with TIL in prostate cancer (PCa). METHODS: Immunohistochemistry (IHC) was used to assess the infiltration of CD3 + , FoxP3 + and CD45RO + cells in the tumor area, tumor margin and adjacent normal-like epithelium of a series of 98 PCa samples with long clinical follow-up. Expression of a panel of 31 TIL-associated genes was analyzed by Taqman Low-Density Array (TLDA) technology in another series of 50 tumors with long clinical follow-up. Kaplan-Meier and Cox proportional hazards regression analyses were performed to determine association of these markers with biochemical recurrence (BCR), need for definitive androgen deprivation therapy (ADT) or lethal PCa. RESULTS: TIL subtypes were present at different densities in the tumor, tumor margin and adjacent normal-like epithelium, but their density and phenotype in the tumor area were the most predictive of clinical outcomes. In multivariate analyses, a high density of T reg (high FoxP3 + /CD3 + cell ratio) predicted a higher risk for need of definitive ADT (HR=7.69, p=0.001) and lethal PCa (HR=4.37, p=0.04). Conversely, a high density of T mem (high CD45RO + /CD3 + cell ratio) predicted a reduced risk of lethal PCa (HR=0.06, p=0.04). TLDA analyses showed that a high expression of FoxP3 was associated with a higher risk of lethal PCa (HR=5.26, p=0.02). Expression of CTLA-4, PD-1, TIM-3 and LAG-3 were correlated with that of FoxP3. Amongst these, only a high expression of TIM-3 was associated with a significant higher risk for definitive ADT in univariate Cox regression analysis (HR=3.11, p=0.01). CONCLUSION: These results show that the proportion of T reg and T mem found within the tumor area is a strong and independent predictor of late systemic progression of PCa. Our results also suggest that inhibition of TIM-3 might be a potential approach to counter the immunosuppressive functions of T reg in order to improve the anti-tumor immune response against PCa.
MEMBER ACCOUNT
登录成功会直接打开下一页。